Fundz

Castle Biosciences Inc reported raising $5.06 Million in an initial SEC Form D filing, from an offering of $5.25 Million

PUBLIC · CSTLJun 13, 2018$5.1M of $5.3M raised

Amount Raised

$5.06 Million

$5.06 Million sold, per SEC Form D (first sale Jun 13, 2018)

Round Type

Venture

FriendswoodBiotechnologyCommunity And LifestyleHealth Care

Quick answer

Castle Biosciences raised $5.06 Million in a funding round, dated June 13, 2018. Castle Biosciences is based in Friendswood, Texas, United States.

How much did Castle Biosciences raise?
Castle Biosciences raised $5.06 Million in a funding round on June 13, 2018.
What does Castle Biosciences do?
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
Where is Castle Biosciences based and how big is it?
Castle Biosciences is based in Friendswood, Texas, United States.
Who are the decision-makers at Castle Biosciences?
Fundz holds 1 contact at Castle Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Community And Lifestyle and Biotechnology around the same time

Companies in the same sectors as Castle Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Vektor Medical raised $11K (Pre-Seed) on July 26, 2018.
  • HealthLynked raised $2M (Seed) on July 26, 2018.
  • Windtree Therapeutics raised $1.5M (Seed) on July 25, 2018.
  • BehaVR raised $500K (Seed) on July 25, 2018.
  • NeuroOne Medical Technologies Corporation raised $538K (Seed) on July 24, 2018.
  • AiVita Biomedical, Inc. raised $17M on July 20, 2018.

Who to call at Castle Biosciences, and when

A new round usually means Castle Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Castle Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Castle Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Castle Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Castle Biosciences

Location

Friendswood, Texas, United States

About

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate-to-severe psoriasis, atopic dermatitis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, Twitter and Instagram. DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, myPath Melanoma, DecisionDx DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Castle Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts19 people are listed at Castle Biosciences. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Castle Biosciences's next move

See what Strategic adds

Castle Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.